Skip to content
    Venrock logo

    Venrock

    Palo Alto, California, United StatesFounded 1969

    Venrock is an American venture capital firm originally established in 1969 as the venture capital arm of the Rockefeller family. The firm focuses on early-stage investing in technology and healthcare companies, partnering with entrepreneurs to build disruptive and successful companies.

    Average disclosed round size is $50.6M (across 284 rounds with reported amounts).

    Find people at Venrock on Goldilocks AI

    Portfolio

    180

    Fund Size

    $650M

    Top Stage

    Series B

    Last 12 Mo

    9

    Team

    Bob Kocher

    Bob Kocher

    Partner

    Brian Ascher

    Brian Ascher

    Partner

    Bryan Roberts

    Bryan Roberts

    Partner

    Cindy Xiong

    Cindy Xiong

    Partner

    Derek Yuan

    Derek Yuan

    Partner

    Ethan Batraski

    Ethan Batraski

    Partner

    Evan Neu

    Evan Neu

    Partner

    Jessica Baron

    Jessica Baron

    Finance Partner and CFO

    Ken Song

    Ken Song

    Partner

    Mariana Mihalusova

    Mariana Mihalusova

    Partner

    Mike Tyrrell

    Mike Tyrrell

    Partner

    Nick Beim

    Nick Beim

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    308 investments
    CompanyRoundAmountDate
    Encoded Therapeutics logoEncoded TherapeuticsSeries F$275MSep 2026
    Arca logoArcaSeries A$48.5MJun 2026
    cAMPfield Therapeutics logocAMPfield TherapeuticsSeries A$180MJun 2026
    CcAMPfieldSeries A$180MJun 2026
    CellCentric logoCellCentricSeries D$220MMay 2026
    Gitar logoGitarSeed$9MApr 2026
    Adcendo ApS logoAdcendo ApSSeries C$75MApr 2026
    GenLogs logoGenLogsSeries B$60MFeb 2026
    Regenxbio logoRegenxbioSeries C$30MJan 2026
    CcAMPfieldSeries A$180MJan 2026
    AAvery TherapeuticsUnknown$69MJan 2026
    AAngitia BioSeries D$130MJan 2026
    Encoded Therapeutics logoEncoded TherapeuticsSeries F$275MJan 2026
    Arca logoArcaSeries A$48.5MJan 2026
    GenLogs logoGenLogsSeries B$60MJan 2026
    cAMPfield Therapeutics logocAMPfield TherapeuticsSeries A$180MJan 2026
    EEncodedSeries F$275MJan 2026
    Angitia Biopharmaceuticals logoAngitia BiopharmaceuticalsSeries D$130MJan 2026
    FINNY logoFINNYSeries A$17MDec 2025
    Euclid logoEuclidSeries A—Sep 2025
    Collate logoCollateSeries A$10MJul 2025
    Adyton logoAdytonSeries A$11MMay 2025
    Astronomer logoAstronomerSeries D$93MMay 2025
    Auditoria logoAuditoriaSeries B$38MFeb 2025
    AAuditoria.AISeries B$38MFeb 2025
    Page 1 of 13

    Top Co-Investors

    Last updated: 7 October 2026